Beth Hoffman

Beth Hoffman

Company: Origami Therapeutics, Inc.

Job title: Founder & Chief Executive Officer


4.00 Optimizing Protein Degraders for Neurodegeneration 9:30 am

Considerations for optimizing the best leads Use of patient iPSC-derived neurons as a translational model Demonstration of PK/PD relationships in preclinical rodent modelsRead more

day: Day One Track B PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.